P-glycoprotein: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
The P-glycoprotein is part of the [[ABC Superfamily|ABC superfamily]] and is involved in drug efflux and therefore multi-drug resistance. The [[ | The P-glycoprotein is part of the [[ABC Superfamily|ABC superfamily]] and is involved in drug efflux and therefore multi-drug resistance. The [[ABC_Superfamily|ABC superfamily]] can be divided into seven subfamilies, P-glycoprotein being a member of the subfamily [[MDR/TAP|MDR/TAP]] <ref>Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A. Andrea Picchianti Diamanti. 2010. PubMed.</ref>. P-glycoprotein can be inhibited by [[Cyclosporine A|cyclosporine A]] and [[Verapamil|verapamil]].<br> | ||
=== References<br> === | === References<br> === | ||
<references /> | <references /> | ||
Revision as of 22:05, 22 November 2010
The P-glycoprotein is part of the ABC superfamily and is involved in drug efflux and therefore multi-drug resistance. The ABC superfamily can be divided into seven subfamilies, P-glycoprotein being a member of the subfamily MDR/TAP [1]. P-glycoprotein can be inhibited by cyclosporine A and verapamil.
References
- ↑ Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A. Andrea Picchianti Diamanti. 2010. PubMed.